Scilex Holding (SCLX) Change in Intangibles (2026)

Scilex Holding (SCLX) recorded quarterly Change in Intangibles of $18.7 million in Q1 2026.

Scilex Holding (SCLX) Change in Intangibles (2026) Analysis & Trends

Scilex Holding's Change in Intangibles history runs 1 years deep, the most recent figure standing at $18.7 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -299.30 Mn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn -
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn -
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn 18.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.70 Mn
Mar 31, 2026 18.70 Mn